A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast Cancer

Clinical trial NCT00140140 · TERMINATED

Trial details

NCT number: NCT00140140
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage IV (Metastatic) Breast Cancer

Start date: 2005-08-01
Primary completion: 2008-02-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.